Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro
Viruses · 2023
DOI: 10.3390/v15040972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Sabina Andreu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Universidad Autónoma de Madrid, C/Darwin, 2 Cantoblanco, 28049 Madrid, Spain. Hauptthemen laut MEDLINE: Coronavirus 229E, Human, COVID-19, RNA Viruses. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A limited number of effective therapies are currently available to treat human coronavirus SARS-CoV-2 and other human coronaviruses, which are responsible for nearly a third of global cases of the common cold. The possibility of new emerging coronaviruses demands powerful new antiviral strategies. Lactoferrin is a well-known protein that possesses anti-inflammatory and immunomodulatory activities, and it has previously shown antiviral activity against several viruses, including SARS-CoV-2. To increase this antiviral activity, here we present bovine liposomal lactoferrin. Liposomal encapsulation of the compound was proven to increase permeability, bioavailability, and time release. In the present work, we compare the antiviral activity of free and liposomal bovine lactoferrin against HCoV229E and SARS-CoV-2 in vitro and in human primary bronchial epithelial cells, and we demonstrated that the liposomal form exerts a more potent antiviral activity than its free form at non-cytotoxic doses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, Universidad Autónoma de Madrid, C/Darwin, 2 Cantoblanco, 28049 Madrid, Spain.
- Centro de Biología Molecular Severo Ochoa, Spanish National Research Council-Universidad Autónoma de Madrid (CSIC-UAM), C/Nicolás Cabrera, 1 Cantoblanco, 28049 Madrid, Spain.
ORCID-Profile: Sabina Andreu, Inés Ripa, Raquel Bello-Morales, José Antonio López-Guerrero
Zitieren
APA
Andreu, S., Ripa, I., Bello-Morales, R., & López-Guerrero, J. A. (2023). Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro. Viruses. https://doi.org/10.3390/v15040972
Vancouver
Andreu S, Ripa I, Bello-Morales R, López-Guerrero JA. Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro. Viruses. 2023. doi:10.3390/v15040972
BibTeX
@article{Andreu2023,
author = {Andreu, Sabina and Ripa, Inés and Bello-Morales, Raquel and López-Guerrero, José Antonio},
title = {Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040972}
}
EUVIMED